Bodiguel E
Service d'Urgences cérébro-vasculaires, Hôpital de la Salpêtrière, Paris.
Rev Neurol (Paris). 1992;148(11):655-62.
Among anti-phospholipid antibodies (APA), anti-cardiolipin antibodies and lupus anticoagulants are associated with arterial and venous thrombo-embolic manifestations. Antiphospholipid antibodies can be secondary to numerous diseases, especially systemic diseases, but they are usually encountered in the primary antiphospholipid syndrome. Neurological manifestations associated with APA are most often, if not always, ischemic in nature: large or small subcortical, often multiple, infarcts and transient ischemic attacks are the usual clinical presentations. Several mechanisms can lead to cerebral ischemia in the primary antiphospholipid syndrome, and their diagnosis is probably important for therapeutic choices. A prospective controlled study has started, which should provide data on the prognosis and management of this syndrome.
在抗磷脂抗体(APA)中,抗心磷脂抗体和狼疮抗凝物与动脉和静脉血栓栓塞表现相关。抗磷脂抗体可能继发于多种疾病,尤其是全身性疾病,但它们通常见于原发性抗磷脂综合征。与APA相关的神经学表现如果不是总是缺血性的,那也是最常见缺血性的:大小不等的皮质下梗死灶,通常为多发性,以及短暂性脑缺血发作是常见的临床表现。几种机制可导致原发性抗磷脂综合征中的脑缺血,其诊断可能对治疗选择很重要。一项前瞻性对照研究已经启动,该研究应能提供有关该综合征预后和管理的数据。